FDA Approved: IBRANCE — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved IBRANCE (palbociclib) through its original NDA. It addresses advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)

Snippet

ORIG AP for IBRANCE (PALBOCICLIB)